Time and accuracy are precious commodities in the oncology world, especially as we observe World Cancer Day and its mission to close the care gap. Yet, for patients with rare cancers, these are often the hardest to come by. While general pathologists in local clinics may be highly skilled, they might encounter a specific rare malignancy only once or twice in their entire career.

This often creates a diagnostic dilemma: How can one accurately identify something that they have never seen before?

Rare cancers are frequently misdiagnosed or diagnosed late, simply because the specialized expertise required to identify them is concentrated only in a few global centers of excellence. In the spirit of World Cancer Day, Medprime Technologies is committed to ensuring that a patient’s geography does not dictate their survival. For a patient based in a remote village or a Tier-III city, the journey to a correct diagnosis is an arduous one, often involving the following steps:

• Physical slide shipping which involves sending glass slides via courier, risking breakage or loss.
• Delay that can stretch into months, hindering the goal of early detection championed by World Cancer Day.
• Expensive travel or consultation fees that make expert opinions inaccessible.

Micalys: Bridging the Distance with Expert-to-Expert Consultation

At Medprime Technologies, we believe that your location should not determine your quality of care. Our Micalys Whole Slide Scanner is designed to eliminate these barriers by digitizing the entire pathology workflow.

Micalys serves as a portal to a global network of specialists, directly supporting the World Cancer Day call for equitable access to treatment. By converting a physical tissue sample into a high-resolution digital version, Medprime enables an Expert-to-Expert (E2E) consultation model that was previously impossible.

From A Remote Village to Global Specialist in Minutes

1. High-Precision Scanning: A local lab technician places the slide into the Micalys scanner. Its automated multi-lens system captures every detail, including 11 layers of Z-stacking for depth, ensuring no critical information is missed.
2. Instant Digital Sharing: Through our Quick Share and Secure IP Sharing features, the digital slide is uploaded to a secure cloud platform. A specialist thousands of miles away can log in and review the slide.
3. Real-Time Collaboration: Through our Robotic Remote Control mode, experts can remotely maneuver the physical microscope stage and adjust magnification in real-time to observe and report on samples from anywhere in the world. With an ultra-low latency of just 250 milliseconds, it delivers a seamless, ‘hands-on’ experience from any distance.
4. The Result: A diagnosis that used to take weeks now takes minutes.

This option to bring a world-class specialist’s eyes to a slide in a remote clinic changes the narrative for rare cancer patients from uncertain hope to timely care and cure.

A Future Without Diagnostic Borders

With the integration of Micalys into the diagnostic ecosystem, Medprime Technologies is building a Second Opinion Network, empowering local pathologists by giving them direct access to specialists. By digitizing and archiving rare cancer cases, we are creating an invaluable living textbook that transcends geographical boundaries. Traditional medical training often relies on the limited physical slides available at a single institution, which rarely cover the full spectrum of uncommon pathologies. Integrating these high-resolution digital records into the medical curriculum allows future doctors and pathologists to study rare morphological patterns that they might otherwise never encounter during their residency. This exposure not only sharpens their ability to identify rare cases early in their careers but also standardizes diagnostic accuracy across the board, ensuring that a patient’s life-saving diagnosis doesn’t depend on whether their doctor has seen that specific rare cell before.

On World Cancer Day, we reaffirm that we are not just digitizing slides; Medprime Technologies is democratizing expertise to ensure that the right approach to cancer care reaches every corner of the globe.